HUTCHMED (China) (HMDCF) Prepaid Assets (2015 - 2026)
HUTCHMED (China)'s (HMDCF) quarterly Prepaid Assets came in at $11.0 million in Q2 2026, down 5.23% year-over-year from $11.6 million in Q2 2025, and up 31.33% quarter-over-quarter from $8.3 million in Q4 2025.
Analysis
HUTCHMED (China) (HMDCF) Prepaid Assets (2015 - 2026) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Prepaid Assets for 11 consecutive years, with $11.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Prepaid Assets fell 5.23% year-over-year to $11.0 million in Q2 2026; TTM through Jun 2026 was $11.0 million, a 5.23% decrease from a year earlier, with the FY2025 full-year figure at $8.3 million, down 88.87% from the prior year.
- Prepaid Assets was $11.0 million for Q2 2026 at HUTCHMED (China), up from $8.3 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $110.9 million in Q4 2022 and troughed at $7.1 million in Q2 2024.
- A 5-year average of $38.8 million and a median of $12.1 million in 2023 frame the typical range for Prepaid Assets.
- The widest YoY moves for Prepaid Assets: up 63.17% in 2025, down 88.87% in 2025.
- Over 5 years, Prepaid Assets stood at $110.9 million in 2022, then decreased by 15.59% to $93.6 million in 2023, then dropped by 19.98% to $74.9 million in 2024, then plunged by 88.87% to $8.3 million in 2025, then soared by 31.33% to $11.0 million in 2026.
- The last three Prepaid Assets figures came in at $11.0 million (Q2 2026), $8.3 million (Q4 2025), and $11.6 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 210.97 Bn | 196.98 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.98 Bn | 177.80 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.09 Bn | 124.24 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.56 Bn | 74.57 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.71 Bn | 56.53 Bn | 1.37 Bn |
| 6 | Moderna | 54.60 Bn | 49.46 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.02 Bn | 30.71 Bn | 992.69 Mn |
| 8 | Biogen | 31.25 Bn | 29.97 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.76 Bn | 29.76 Bn | 1.16 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.95 Mn |
| Dec 31, 2025 | 8.34 Mn |
| Jun 30, 2025 | 11.56 Mn |
| Dec 31, 2024 | 74.91 Mn |
| Jun 30, 2024 | 7.08 Mn |
| Dec 31, 2023 | 93.61 Mn |
| Jun 30, 2023 | 12.05 Mn |
| Dec 31, 2022 | 110.90 Mn |
| Jun 30, 2022 | 19.89 Mn |
| Mar 31, 2021 | 27.27 Mn |
| Dec 31, 2019 | 56.60 Mn |
| Sep 30, 2019 | 19.52 Mn |
| Jun 30, 2019 | 15.23 Mn |
| Mar 31, 2019 | 18.25 Mn |
| Dec 31, 2018 | 4.25 Mn |
| Jun 30, 2018 | 4.96 Mn |
| Dec 31, 2017 | 2.57 Mn |
| Jun 30, 2017 | 1.07 Mn |
| Dec 31, 2016 | 699,000.00 |
| Dec 31, 2015 | 19,000.00 |